The New York State Senate Commends Bob Vince
The New York State Senate recently adopted a legislative resolution commending Prof. Robert Vince upon the occasion of his designation as a 2017 Inductee into the Auburn Alumni Hall of Distinction.
The resolution underscored that "It is the custom of this Legislative Body (NY State Senate) to take note of and publicly acknowledge individuals who have distinguished themselves through their exemplary careers, accomplishments, and purposeful lives of service to their community".
The resolution further noted "That this Legislative Body pause in its deliberations to commend Robert Vince upon the occasion of his designation as a 2017 Inductee into the Auburn Alumni Hall of Distinction."
Profs Vince and More Create New Antidote for Acetaminophen Poisoning
UMN researchers create new antidote for acetaminophen poisoning
Swati More, PhD, and Robert Vince, PhD, Professor and Director of the Center for Drug Design, discovered a potential new drug that works as an antidote to acetaminophen poisoning. It’s named ψ-Glutathione (Pseudo-Glutathione), similar to the naturally-occurring compound glutathione. A report of the compound’s efficacy was recently published in Chemical Research in Toxicology. Read More
Investigative Ophthalmology and Visual Science
Potential Early Detection of Alzheimer's Disease
Prof Vince Receives Antonin Holy Memorial Award from ISAR
Prof Robert Vince has been awarded the Antonin Holy Memorial Award from the International Society for Antiviral Research (ISAR).
Message from the Director
The Center for Drug Design (CDD) was created to combine research and scholarship leading to the development of novel drugs for therapeutic applications, such as HIV, cancer, neurological diseases, dermatological agents, infectious diseases, novel processes, and medical devices. The Center for Drug Design combines the best of academic tradition along with an expectation of innovation and independence, and provides significant value for our academic and research community.
Modulation of Transcription Factor Signaling with Covalent Small Molecule Inhibitors
May 3, 2017
2-520 Moos Tower
11:30 AM - 12:30 PM
Transcription factors (TFs) are DNA-binding proteins that modulate the transfer of genomic information to mRNA (and ultimately proteins) in cells. Aberrant TF activity causes many human diseases, such as chromic inflammation (elevated NF-kB signaling) and prostate cancer (elevated androgen receptor signaling), among others. Read More